Zobrazeno 1 - 10
of 160
pro vyhledávání: '"Amit Janu"'
Autor:
Arpita Sahu, Aditi Venkatesh, Aman Snehil, Abhishek Mahajan, Amit Janu, Ayushi Sahay, Epari Sridhar
Publikováno v:
Exploration of Targeted Anti-tumor Therapy, Vol 5, Iss 3, Pp 766-779 (2024)
Aim: Supratentorial ependymoma (STE) is a rare tumor with distinct genetic alterations, whose imaging features have been scarcely studied. This study aims to review the computed tomography (CT) and magnetic resonance imaging (MRI) features of a cohor
Externí odkaz:
https://doaj.org/article/b23d17bcf1774303b61df1553f900d02
Autor:
Jayashree Thorat, Surabhi Bhat, Manju Sengar, Akshay Baheti, Sweta Bothra, Maheema Bhaskar, Sandeep Prakashnarain Tandon, Sanjay K. Biswas, Gaurav V. Salunke, George Karimundackal, Virendra Kumar Tiwari, C.S. Pramesh, Neha Sharma, Venkatesh Kapu, Thomas Eipe, Bhausaheb Pandurang Bagal, Lingaraj Nayak, Avinash Bonda, Amit Janu, Alok Shetty, Hasmukh Jain
Publikováno v:
JCO Global Oncology, Vol , Iss 10 (2024)
PURPOSEFebrile neutropenia (FN) is a serious complication in hematologic malignancies, and lung infiltrates (LIs) remain a significant concern. An accurate microbiological diagnosis is crucial but difficult to establish. To address this, we analyzed
Externí odkaz:
https://doaj.org/article/1d5a23b52e0f43fa840bec692254207e
Autor:
Vanita Noronha, MBBS, MD, DM, Nandini S. Menon, MBBS, MD, DrNB, Vijay Maruti Patil, MBBS, MD, DM, M.V. Chandrakanth, MBBS, MD, DM, Sucheta More, BAMS, MSc, Aditya Dhanawat, MBBS, MD, Oindrila Roy Chowdhary, MSc, Ajaykumar Chandrabhan Singh, MBBS, MD, DM, Supriya Goud, BAMS, PGDCR, Srushti Shah, BHMS, PGDCR, Naveen Karuvandan, MBBS, MD, DM, Kunal Naishadh Jobanputra, MBBS, MD, DM, Darshit Kalpeshkumar Shah, DM, Minit Jalan Shah, MBBS, MD, DM, Rupjyoti Sarma, MBBS, MD, DM, Dhwaniben Patel, MBBS, MD, Ritam Joarder, MBBS, MD, Prashant Kumar, MBBS, MD, Anupa John, MBBS, MD, Jaspreet Kaur, MBBS, MD, Saurabh Bagra, MBBS, MD, Nilendu Purandare, MBBS, DNB, Amit Janu, MBBS, DMRD, DNB, Abhishek Mahajan, MBBS, MD, MRes, Kumar Prabhash, MBBS, MD, DM
Publikováno v:
JTO Clinical and Research Reports, Vol 5, Iss 1, Pp 100622- (2024)
Introduction: The outcomes in advanced NSCLC have improved owing to the availability of more effective systemic and improved supportive care. This has increased the number of patients who seek treatment in the third line and beyond setting. We conduc
Externí odkaz:
https://doaj.org/article/fd374af717524311a1871ffda94513f0
Autor:
Akhil Kapoor, Vanita Noronha, Vijay Patil, Nandini Menon, Ravindra Nandhana, Amit Kumar, Abhishek Mahajan, Amit Janu, Rajiv Kumar, Kumar Prabhash
Publikováno v:
South Asian Journal of Cancer, Vol 12, Iss 02, Pp 179-184 (2023)
Externí odkaz:
https://doaj.org/article/7155c6c2688e43598d81f4234d9a7dbd
Publikováno v:
Cancer Research, Statistics, and Treatment, Vol 6, Iss 1, Pp 115-119 (2023)
Externí odkaz:
https://doaj.org/article/2c3fc970883e41e8a8565e04628508cf
Autor:
Akhil Kapoor, Vanita Noronha, Vijay M. Patil, Amit Joshi, Nandini Menon, Amit Kumar, Abhishek Mahajan, Amit Janu, Rajiv Kumar, Kumar Prabhash
Publikováno v:
South Asian Journal of Cancer, Vol 11, Iss 04, Pp 340-345 (2022)
Abstract Kumar Prabhash Background The development of immune-related adverse effects (irAEs) can corroborate with the response to immune checkpoint inhibitors (ICIs), including programmed cell death 1 (PD1) inhibitors. However, there is extremely l
Externí odkaz:
https://doaj.org/article/671a39755ead4f47b24d1a7dc79987d1
Publikováno v:
Journal of Global Infectious Diseases, Vol 15, Iss 3, Pp 121-123 (2023)
Delftia acidovorans (D. acidovorans) is an aerobic, nonfermentative Gram-negative bacillus infrequently isolated from clinical specimens. The pathogenicity and clinical significance of the organism has not been ascertained due to uncommon clinical is
Externí odkaz:
https://doaj.org/article/659458289ff7409096941ee44300f6ba
Autor:
Satvik Khaddar, Akhil Kapoor, Vanita Noronha, Vijay M. Patil, Nandini Menon, Abhishek Mahajan, Amit Janu, Rajiv Kumar, Nilendu Purandare, Kumar Prabhash
Publikováno v:
South Asian Journal of Cancer, Vol 11, Iss 03, Pp 243-248 (2022)
Abstract Akhil Kapoor Introduction The prognosis of anaplastic lymphoma kinase (ALK) fusion-positive metastatic non-small cell lung cancer (mNSCLC) patients has improved drastically since the introduction of targeted therapies. Apart from age, perf
Externí odkaz:
https://doaj.org/article/b9326ac424a9419fb6f14cc34e01d77e
Autor:
Arpita Sahu, Ronny Mathew, Renuka Ashtekar, Archya Dasgupta, Ameya Puranik, Abhishek Mahajan, Amit Janu, Amitkumar Choudhari, Subhash Desai, Nandakumar G. Patnam, Abhishek Chatterjee, Vijay Patil, Nandini Menon, Yash Jain, Venkatesh Rangarajan, Indraja Dev, Sridhar Epari, Ayushi Sahay, Prakash Shetty, Jayant Goda, Aliasgar Moiyadi, Tejpal Gupta
Publikováno v:
Frontiers in Nuclear Medicine, Vol 3 (2023)
IntroductionConventional magnetic resonance imaging (MRI) has limitations in differentiating tumor recurrence (TR) from radionecrosis (RN) in high-grade gliomas (HGG), which can present with morphologically similar appearances. Multiparametric advanc
Externí odkaz:
https://doaj.org/article/146284c5580c444090d38d1b985d106d
Autor:
Akhil Kapoor, MD, DM, Vanita Noronha, MD, DM, Vijay Patil, MD, DM, Nandini Menon, MD, DNB, Amit Joshi, MD, DM, Amit Kumar, MD, DM, Ajay Kumar Singh, MD, DM, Abhishek Mahajan, MD, Amit Janu, MD, Rajiv Kumar, MD, Trupti Pai, MD, Anuradha Chougule, MD, Omshree Shetty, MD, Kumar Prabhash, MD, DM, ECMO
Publikováno v:
JTO Clinical and Research Reports, Vol 4, Iss 1, Pp 100443- (2023)
Introduction: ALK inhibitors are one of the success stories in precision medicine for treating patients with advanced ALK-positive NSCLC. Nevertheless, developing countries have substantial constraints in using ALK inhibitors, with limited data from
Externí odkaz:
https://doaj.org/article/93d145c0f2574e66b581ca7619604c26